218 related articles for article (PubMed ID: 30219706)
1. PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.
Ding Z; Dhruv H; Kwiatkowska-Piwowarczyk A; Ruggieri R; Kloss J; Symons M; Pirrotte P; Eschbacher JM; Tran NL; Loftus JC
Neoplasia; 2018 Oct; 20(10):1045-1058. PubMed ID: 30219706
[TBL] [Abstract][Full Text] [Related]
2. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
[TBL] [Abstract][Full Text] [Related]
3. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
[TBL] [Abstract][Full Text] [Related]
4. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
[TBL] [Abstract][Full Text] [Related]
5. TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.
Paulino VM; Yang Z; Kloss J; Ennis MJ; Armstrong BA; Loftus JC; Tran NL
Mol Cancer Res; 2010 Nov; 8(11):1558-67. PubMed ID: 20881009
[TBL] [Abstract][Full Text] [Related]
6. A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.
Ding Z; Roos A; Kloss J; Dhruv H; Peng S; Pirrotte P; Eschbacher JM; Tran NL; Loftus JC
Mol Cancer Res; 2018 Feb; 16(2):322-332. PubMed ID: 29117939
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.
Ding Z; Dong Z; Yang Y; Fortin Ensign SP; Sabit H; Nakada M; Ruggieri R; Kloss JM; Symons M; Tran NL; Loftus JC
Am J Pathol; 2020 Oct; 190(10):2165-2176. PubMed ID: 32693062
[TBL] [Abstract][Full Text] [Related]
8. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
9. PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA.
Ying Z; Giachini FR; Tostes RC; Webb RC
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1657-63. PubMed ID: 19759375
[TBL] [Abstract][Full Text] [Related]
10. Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.
Gadepalli R; Kotla S; Heckle MR; Verma SK; Singh NK; Rao GN
J Biol Chem; 2013 Oct; 288(43):30815-31. PubMed ID: 24025335
[TBL] [Abstract][Full Text] [Related]
11. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
12. Detrimental Role of PDZ-RhoGEF in Pathological Cardiac Hypertrophy.
Huang J; Qu Q; Dai Y; Ren D; Qian J; Ge J
Hypertension; 2023 Feb; 80(2):403-415. PubMed ID: 36448462
[TBL] [Abstract][Full Text] [Related]
13. Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.
Wang H; Han M; Whetsell W; Wang J; Rich J; Hallahan D; Han Z
Oncogene; 2014 Mar; 33(12):1558-69. PubMed ID: 23563176
[TBL] [Abstract][Full Text] [Related]
14. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
15. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
17. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
[TBL] [Abstract][Full Text] [Related]
18. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
19. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Gαq activates RhoJ through PDZ-RhoGEF.
Cervantes-Villagrana RD; Color-Aparicio VM; Castillo-Kauil A; García-Jiménez I; Beltrán-Navarro YM; Reyes-Cruz G; Vázquez-Prado J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
